Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Newcastle Systems Introduces FH Series Mobile Powered Workstation to Meet Increased Healthcare Demand


News Image

Newcastle Systems, a leading provider of mobile-powered workplace solutions designed to make warehouses, manufacturing facilities and retail floors more efficient, today announces their latest product in response to increased demand from healthcare providers amid the COVID-19 pandemic.

The FH Series Mobile Field Health Station is designed to mobilize and power laptops, printers, scanners and other critical devices for 8+ hours at a time at outdoor testing sites, temporary healthcare facilities and more. It also allows healthcare providers to print, test and collect patient data from the bedside, while keeping a safe distance.

“Mobilizing these commonly-used devices will cut down on wasted steps, increase efficiency and a provider’s capacity to service more patients in a timely manner,” said Newcastle CEO John O’Kelly. “Providing a workstation for each employee that can be easily sanitized and used at a safe distance will eliminate the need for shared stations and help facilities protect their employees.”

The FH Series comes standard with an adjustable top antimicrobial HDPE shelf that can be easily wiped down and disinfected. The units are offered with standard 5” or 8” rugged locking casters that accommodate use in parking lots, on gravel or other uneven surfaces, and a swappable lithium battery system for 24/7 operation. Once the battery charge is depleted, it can be easily swapped in seconds with a fully charged battery from the system’s stand-alone charging station. Batteries can be charged in about 4 hours.

“We’ve seen an increased demand over the last few weeks and have worked quickly to create a product that can help our healthcare heroes work as efficiently and safely as possible through the tough weeks to come,” said O’Kelly. “We want to do everything we can to help the helpers. We’re all in this together.”

The FH Series can also be customized with optional accessories to accommodate your current computer and devices, or any combination of scanners, printers, tablet, touchscreen or laptop/keyboard. Additional organization/storage options, shelving, and LED lighting are also available.

To learn more information about the FH Series Mobile Powered Workstation, please contact Newcastle’s sales team 1-781-935-3450 or visit https://www.newcastlesys.com/fh-series-mobile-field-health-testing-stations.

About Newcastle Systems

Newcastle Systems, Inc. is a provider of workplace mobility solutions that include a range of mobile carts for every workstation need with a unique, integrated power system that enables companies to maximize workplace efficiencies with minimal investment. Newcastle Systems mobility solutions are in place around the world helping reduce footsteps in warehouses, speed up receiving, picking and shipping operations, improve staffing efficiencies on retail floor, and provide convenience and ergonomic benefits for employees in manufacturing, education, distribution, military and government sectors. For more information, visit http://www.newcastlesys.com or e-mail sales@newcastlesys.com.

Share article on social media or email:

ERT Offers First Patient-Administered ECG Assessment for Continuation of Clinical Trials during COVID-19


KardiaMobile 6L is a hand-held, patient-administered ECG device

KardiaMobile 6L Device

By combining AliveCor’s advanced technology with our proven software and workflow platform, we are enabling our customers to continue developing new medical treatments during the COVID-19 pandemic, regardless of whether trial patients have physical access to investigative site personnel

ERT, a global data and technology company that captures critical endpoint data while minimizing uncertainty and risk in clinical trials, today announced a first-of-its-kind partnership with AliveCor, the leader in AI-based, personal ECG technology. The partnership enables ERT to capture digital cardiac safety data with KardiaMobile 6L, the only FDA-cleared personal ECG for patient-administered 6-lead data collection.

“By combining AliveCor’s advanced technology with our proven software and workflow platform, we are enabling our customers to continue developing new medical treatments during the COVID-19 pandemic, regardless of whether trial patients have physical access to investigative site personnel,” said Ellen Street, Executive Vice President of Cardiac Safety of ERT. “The device’s ease of use, combined with ERT’s centralized overread and data collection methodology make it an ideal solution for ensuring patient safety during ongoing clinical trials.”

KardiaMobile 6L is a hand-held, 6-lead personal ECG that records Lead II data without the attachment of electrodes. Data captured from the device will be integrated into ERT’s software and workflow platform and read by ERT cardiologists to ensure patient safety during the clinical development of new medical treatments. ERT provides high quality measurements for QTc, QRS, and other ECG intervals that enable efficacy and safety monitoring during clinical trials.

“ERT’s experience in analyzing millions of ECGs and their dedication to patient safety make them the gold standard in clinical trial cardiac safety assessment,” said Priya Abani, CEO of AliveCor. “We look forward to this partnership and to delivering the innovative solutions and valuable data that clinical trial sponsors require.”

Click here to learn more about ERT’s virtual clinical trial capabilities.

About ERT

ERT is a global data and technology company that minimizes uncertainty and risk in clinical trials so that its customers can move ahead with confidence. With nearly 50 years of clinical and therapeutic experience, ERT balances knowledge of what works with a vision for what’s next, so it can adapt without compromising standards.

Powered by the company’s EXPERT® technology platform, ERT’s solutions enhance trial oversight, enable site optimization, increase patient engagement and measure the efficacy of new clinical treatments while ensuring patient safety. In 2019, 75% of all FDA drug approvals came from ERT-supported studies. Pharma companies, biotechs and CROs have relied on ERT solutions across 15,000 studies, spanning more than four million patients to date. By identifying trial risks before they become problems, ERT enables customers to bring clinical treatments to patients quickly – and with confidence.

For more information, go to ert.com or follow us on LinkedIn and Twitter.

About AliveCor

AliveCor, Inc. is transforming cardiological care using deep learning. The FDA-cleared KardiaMobile 6L device is the most clinically validated personal ECG solution in the world. KardiaMobile provides instant detection of Atrial Fibrillation, Bradycardia, Tachycardia, and Normal rhythm in an ECG. Kardia is the first AI enabled platform to aid patients and clinicians in the early detection of atrial fibrillation, the most common arrhythmia and one associated with a highly elevated risk of stroke. AliveCor’s enterprise platform allows third party providers to manage their patients and customers’ heart conditions simply and profitably using state-of-the-art tools that provide easy front-end and back-end integration to AliveCor technologies. AliveCor was named the No.1 artificial intelligence company in Fast Company’s Top 50 Most Innovative Companies. AliveCor is a privately-held company headquartered in Mountain View, Calif. “Consumer” or “Personal” ECGs are ECG devices available for direct sale to consumers. For more information, visit alivecor.com.

Share article on social media or email:



OLEO Releases New Boost+ CBD Drink Mix for On-The-Go Recovery


The first single-serving flavorless CBD supplement that adds a boost of OleoCBD™ to any hot or cold beverage

OLEO™ CBD Boost +

“We love hearing from customers about what products they want to see us launch next. This one has been requested over and over, so we’re finally making it happen!,” said Skyler Bissell, CEO and Co-Founder of OLEO, Inc.

OLEO, Inc., creator of the most effective CBD supplement for fitness recovery, is excited to announce the launch of OLEO™ CBD Boost + — the first single-serving flavorless CBD supplement that adds a boost of OleoCBD™ to any hot or cold beverage or recipe. As the most versatile grab-and-go essential for active lifestyle enthusiasts, CBD Boost + is a prepackaged, premeasured, and 100% water-soluble flavorless CBD powder with 25mg of OleoCBD™. Quickly and easily add one packet of CBD Boost + into any refreshment before or after physical activity to renew the body, revive the mind, and reach peak performance.

“We love hearing from customers about what products they want to see us launch next. This one has been requested over and over, so we’re finally making it happen!,” said Skyler Bissell, CEO and Co-Founder of OLEO, Inc. “2020 is going to be a big year for us and I’m excited for everyone to see the new projects we have in the works. OLEO is about more than just building products, it’s about creating a community and helping people live better lives.”

Founded in 2015 in Seattle, OLEO™ is North America’s leading purveyor of powdered CBD drink mixes for a healthy, active lifestyle. Using its own proprietary and patent-pending micro-encapsulation technology, OLEO™ converts pure CBD oil into a water-soluble powder known as OleoCBD™. This technology ensures that OLEO™ and Powered by OLEO™ partner products offer double the bioaccessibility of regular CBD, meaning higher quantities of cannabidiol can be absorbed by the body. The micro-encapsulation process additionally removes any bitter aftertaste, allowing both the flavored and non-flavored drink mixes to have a clean, pleasant taste compared to typical CBD tinctures.

In addition to the new CBD Boost + on-the-go packets, OLEO™ drink mixes are also available in a variety of flavorless and flavored multi-serving jars and single-serving packets that combine the benefits of 25mg of OleoCBD™ per serving with the power of functional ingredients such as freeze-dried coconut water and real rooibos and black tea, available with or without caffeine to either energize or unwind. All of OLEO™’s drink mixes dissolve quickly in cold or hot water, making them easy to consume at any point throughout the day, helping support full body recovery after an active day. The entire product line not only offers consistent made-in-the-USA quality, but is also guaranteed to be 100% THC-free with zero intoxicating effects. It’s hydration without the high.

OLEO™ CBD Boost + is available now for purchase online and at key retailers in the United States. For more information on OLEO, Inc., OleoCBD™, and Powered by OLEO™, please visit OLEOlife.com.

About OLEO, Inc.

OLEO, Inc. is a consumer-packaged goods company thoughtfully designing potent, water-soluble CBD products for the active lifestyle community. OLEO offers a collection of powdered beverages infused with their active ingredient OleoCBD™, including CBD Boost +, the new flavorless CBD powder for on-the-go recovery. OleoCBD™ is created with a patent-pending Micro-Encapsulation technology that masks any bitter aftertaste and makes the CBD content two-times more bioaccessible, leading to better absorption and longer lasting effects. OLEO is playing a tremendous role in the advancement of cannabinoid technology, testing standards and consumer product offerings, and helping to make the cannabinoid and hemp industry more trusted, beneficial and approachable for all.

Share article on social media or email:

Spa Revolutions Introduces Affiliate Program For Existing Spa Clients and Free Samples of New On-Demand, Sanitary Thermal Wellness Technology


News Image

Earlier this year, Spa Revolutions’ engineers patented a breakthrough system of four, water-activated thermaBliss® Charges™ that enhance treatments across all areas of spa, beauty, and wellness while eliminating the need for electrical appliances. With roots fifteen years long in the spa and salon industry, the innovative company bringing the patented mineral energy technology to market, has already revolutionized paraffin and heated massage with self-heating and cooling, PerfectSense Paraffin® and thermaBliss® Stones®/Shells®.

Now, with the current state of the industry, they have begun an affiliate program for new and existing clients that affords them a 30% commission as credit toward inventory purchase when their clients purchase at-home spa products. When signing up for the program, affiliates can also receive free samples of the new thermaBliss Charges which allows clients the ability to test the new self-heating technology including in adjacent industries Chiropractic, Physical Therapy and Dental.

The power of new water-activated thermal wellness technology comes in portable, lightweight, appliance-free stick packs that impacts other industries beyond wellness, health, including food service and delivery, outdoor and on the go as well as medical and military. It offers game-changing levels of thermal enhanced treatments to mobile spa operators – the fastest-growing segment of the spa industry, which serves hotel services, in-home/VIP, special events and corporate wellness programs.

All thermaBliss Charges (Level 1.0 Body, Level 2.0 Body, Facial Blend, and Glacial Blend) activate with standard tap water anywhere on planet earth to create professional thermal wellness applications lasting 90+ minutes.

thermaBliss Charge technology delivers cost-effective, on-demand, portable heat featuring:

  • Thermal Wellness Applications lasting up to 90 minutes
  • Sustained mineral energy activated instantly with water
  • No appliance, no battery, electricity-free, flame-free – safe
  • Portable, lightweight & compact
  • Client-exclusive, single-use and sanitary

Enhancement Tools include:

MASSAGE: Lava Shells/Lava Stones/Glacial Shells, ThermaHerbal Poultice

SKINCARE: ThermaFusion Facial Masque, Paraffin Anywhere

MANI/PEDI: PerfectSense Parrafin, Paraffin Anywhere

WAXING: Depilatory Anywhere

The recent thermaBliss Charge technology breakthroughs, powered by LavaGel® have facilitated compact, lightweight stick pack solutions, containing the natural minerals iron, magnesium, and salt for on-demand activation, onsite with tap water. This innovation has enabled the current dynamic expansion of thermal wellness solutions.

The thermaBliss Collection has been awarded Dermascope Magazine’s 2020 Aesthetician’s Choice Awards Best Massage Product and is already embraced by the crème de la crème of the spa marketplace, including marquee properties such as Cal-a-Vie (Travel+Leisure World #2), prestigious Manhattan Mandarin Oriental, and dozens of other standard-setting properties. Spa Revolutions’ is dedicated to empowering credentialed practitioners who share their mutual passion for enhancing the client experience. Globally, over 4,000 leading spas, salons, and wellness centers use thermaBliss thermal wellness enhancements to improve outcomes, delight clients, and increase profits.

                                                                        ###

EDITOR’S NOTE: For more information about Spa Revolutions and to arrange to speak with a company spokesperson, please contact Nancy Trent or Pamela Wadler at 212-966-0024 or pam@trentandcompany.com.

Share article on social media or email:

BayMark Expands Opioid Addiction Treatment Services In Ohio


“We are pleased to be expanding access into Northern Ohio. MedMark offers unrivaled care for those struggling with opioid addiction, and will continue that practice as we welcome patients in our newest facility.” – Frank Baumann, Chief Operating Officer.

BayMark Health Services has announced the opening of MedMark Treatment Centers Kent, expanding access to opioid addiction treatment services into northern Ohio. Conveniently located at 2500 State Route 59, 30 minutes outside of Akron, MedMark Kent is accepting new patients and has safety precautions in place to do so with our patient’s health top of mind as we address both the coronavirus pandemic and the opioid epidemic.

MedMark Kent will provide medically-supervised, medication-assisted treatment (MAT), administering methadone or buprenorphine, counseling and support services for those seeking treatment for opioid use disorder. As essential medical facilities, MedMark Treatment Centers are accepting new patients and following all CDC guidelines for social distancing and sanitizing throughout the facility.

“Ohio is currently experiencing the impact of two significant public health emergencies,” commented David K. White, Ph.D., CEO of BayMark Health Services. “The opioid epidemic has hit Ohio incredibly hard, and a significant amount of loss has been experienced throughout the state over many years. Now the coronavirus pandemic is impacting all citizens and intensifying that loss. We proceeded with the opening of our new location in Kent to ensure that as many people as possible have access to opioid treatment, both during this stressful and uncertain time, as well as once the coronavirus has passed.”

MedMark Treatment Centers are known across the country as providers of comprehensive, individualized treatment for opioid use disorder. Through medication management and counseling, MAT reduces the symptoms of withdrawal and cravings, paving the way for patients to focus on addressing the causes and consequences of their addiction and supporting them to regain stability in their lives. Additionally, MedMark Kent will provide addiction education, relapse prevention, lab testing, coordinated care for pregnant women and linkages to community resources to assist patients on their path to recovery.

Chief Operating Officer Frank Baumann added, “We are pleased to be expanding access into Northern Ohio. MedMark offers unrivaled care for those struggling with opioid addiction, and will continue that practice as we welcome patients in our newest facility. No matter what circumstances we face, our staff puts our patient’s safety, well-being and recovery first. ”

For more information on MedMark and our services visit: http://www.MedMark.com.

To inquire about admission or make a referral, contact Kathleen Mahoney, Treatment Center Director, at 330.552.4000.

About BayMark Health Services:

BayMark Health Services provides medication-assisted treatment to 53,000+ patients in recovery from substance use disorder across the United States and Canada. Our outpatient programs deliver medically-supervised treatment, in a variety of modalities and settings, to meet the diverse needs of our patients who struggle with the use of opioids, alcohol and other prescription and illicit substances.

The BayMark continuum of patient-focused services includes: highly structured opioid treatment programs utilizing methadone or buprenorphine and outpatient buprenorphine treatment programs, both of which incorporate counseling as part of an individualized treatment plan for opioid use disorder. Additionally, ambulatory withdrawal management services with naltrexone therapy, and inpatient detoxification services are offered for a variety of substance use disorders.

Share article on social media or email:

Understanding the Changes & Leveraging the Opportunity, Upcoming Webinar Hosted by Xtalks


Xtalks Life Science Webinars

By understanding this evolving regulatory landscape, device manufacturers across the globe can better position their products to adapt to these changes in support of their device development programs.

Medical devices play an increasingly critical role in the health and quality of life for millions of people worldwide. While clinical trials for medical devices have many similarities to those for pharmaceuticals, the regulatory evaluation of devices is distinct from that of drugs – and there are critical differences in the way the device trials are designed and executed.

In a live webinar taking place on Monday, May 11, 2020 at 3pm KST (Korea), Premier Research’s Nach Davé, Vice President, Development Strategy, and Marlis Sarkany, Senior Medical Director, draw on their extensive experience in both medical device and clinical product development to share what manufacturers need to know. The pair will explore the latest US and European medical device regulatory pathways, agency expectations and other critical best practices.

To reflect the substantial technological and scientific advances made by the medical device sector and to respond to the need for regulations that would significantly tighten the controls around medical devices, the European Commission published the EU Medical Devices Regulation (MDR) on May 5, 2017.

These regulations seek to set the standard for medical device regulation globally and impact the entire product development cycle, from concept to clinical trial conduct and post-marketing surveillance. Manufacturers will need to conduct more rigorous clinical investigations than ever on both safety and effectiveness to support their claims both in Europe and in the US.

By understanding this evolving regulatory landscape, device manufacturers across the globe can better position their products to adapt to these changes in support of their device development programs. Register for the webinar today for an in-depth look at the changes being proposed and the requirements that will need to be met by device manufacturers willing to do business in Europe and beyond.

For more information or to register for this event, visit Asia-Pacific – Taking Device Clinical Development to the US & Europe: Understanding the Changes & Leveraging the Opportunity.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Boston Medical Center Partners with Digital Health Company Rimidi to Add Post-Partum Remote Monitoring for High-Risk Pregnancies


News Image

“This project to address maternal and infant morbidity and mortality due to hypertensive disorders in pregnancy is a great example of how technology can support more proactive and preventative management of a condition that is a public health crisis across the US.”

Boston Medical Center (BMC) today announced a partnership with Rimidi, a cloud-based software platform that enables a more efficient model of care for patients with chronic conditions, to remotely monitor blood pressure for women experiencing high-risk pregnancies. Healthcare experts in the Department of Obstetrics and Gynecology at BMC, including recent medical school graduates, will be the first to use Rimidi’s platform, which has been integrated into the academic medical center’s electronic health record, Epic.

“Women who have gestational hypertension or preeclampsia are considered ‘high-risk’ during and after pregnancies, and can benefit from close monitoring,” said Christina Yarrington, MD, FACOG, an obstetrics and gynecology physician and director of labor and delivery at Boston Medical Center. “In the midst of the COVID-19 pandemic, adding the capability to remotely monitor blood pressure in these patients is especially pressing, as we are trying to limit their exposure to healthcare settings.”

The team at BMC will use Rimidi’s cardiovascular disease platform view, which combines relevant EHR data, with patient-generated blood pressure data from a cellular-connected blood pressure cuff. This allows physicians to manage better outcomes based on actionable, real-time information. According to Yarrington, who is also an assistant professor of obstetrics and gynecology at Boston University School of Medicine, the remote monitoring program will start with a cohort of approximately 60 patients.

“Adverse cardiovascular outcomes like heart attack and stroke—whether pregnancy-related or not—are one of the most preventable causes of mortality in the United States,” said Lucienne Ide, MD, PhD, founder and chief health innovator at Rimidi. “This project to address maternal and infant morbidity and mortality due to hypertensive disorders in pregnancy is a great example of how technology can support more proactive and preventative management of a condition that is a public health crisis across the US.”

With the risk of COVID-19, healthcare systems are taking extra precautions in treating their patients. The adoption of Rimidi’s platform will not only allow physicians at BMC to cut back on fear of exposure by monitoring their patients remotely, but also add in an extra layer of medical support when patients need it most.

To learn more about Boston Medical Center and the steps it’s taking during COVID-19 to better monitor patients, including its visitor policy, visit http://www.bmc.org. For the latest news and information about Rimidi and its technology, including its COVID-19 triage and monitoring application, visit http://www.rimidi.com.

About Boston Medical Center

Boston Medical Center is a private, not-for-profit, 514-bed, academic medical center that is the primary teaching affiliate of Boston University School of Medicine. It is the largest and busiest provider of trauma and emergency services in New England. Boston Medical Center offers specialized care for complex health problems and is a leading research institution, receiving more than $97 million in sponsored research funding in fiscal year 2018. It is the 15th largest funding recipient in the U.S. from the National Institutes of Health among independent hospitals. In 1997, BMC founded Boston Medical Center Health Plan, Inc., now one of the top ranked Medicaid MCOs in the country, as a non-profit managed care organization. Boston Medical Center and Boston University School of Medicine are partners in Boston HealthNet – 14 community health centers focused on providing exceptional health care to residents of Boston. For more information, please visit http://www.bmc.org.

About Rimidi

Rimidi is a cloud-based software platform that enables personalized management of health conditions across populations. Created by doctors, Rimidi avoids the disconnect in connected care by combining patient-generated health data with clinical data from the EHR to drive patient-specific clinical insights and actions. The net effect is a better health system with optimized clinical workflows that enable better decisions, better relationships, better outcomes and ultimately a better healthcare system. For more information, visit rimidi.com and follow us on Facebook, Twitter and LinkedIn.

Media Contacts:

Cortney Williams

ARPR, on behalf of Rimidi

(855) 300-8209

cortney@arpr.com

Jazmin Holdway

Communications Associate, Boston Medical Center

(617) 638.6838

Jazmin.Holdway@bmc.org

Share article on social media or email:



What’s That? Spotting Skin Cancer Early Can Save Your Life


“We bring an unmatched level of services to all of our patients and are confident in our approach to treat skin cancer most effectively and efficiently,” says Dr. Foster.

Summer: it’s a recipe for spending more time outdoors. Depending on your activities, all that extra time in the sun is sure to leave you with harmful exposure to ultraviolet (UV) rays if you aren’t using proper sun protection. Did you know more than five million new cases of skin cancer are diagnosed each year? And of those, roughly 85 percent of melanoma cases are associated with exposure to UV radiation from the sun.

Skin cancer is the most common form of cancer in the United States. Every year, skin cancer diagnoses outnumber new cases of many other types of cancers such as breast, colon, lung, and prostate.

“Anyone can get skin cancer. Regardless of skin color or background,” says Medical Director of Florida Dermatology and Skin Cancer Centers, Dr. K. Wade Foster. “Fortunately, skin cancer is one of the most preventable forms of cancer and we can lessen our chances by taking a few important measures.”

So, what can we do to help protect ourselves from a diagnosis?

Check yourself: Florida Dermatology and Skin Cancer Centers recommends that you regularly perform a self-exam by checking yourself in the mirror and looking for any new, unusual or changing areas, and reporting those to your dermatologist right away. An annual skin exam can also help identify suspicious growths, moles, and other dermatological changes. Areas of the skin that are exposed to the sun are more prone to develop moles or certain growths, and because of this, it’s very important to have an experienced dermatologist or licensed medical professional conduct a yearly body analysis to check all areas of your body, including your scalp, neck, and back.

What should you look for?

Florida Dermatology and Skin Cancer Centers (FLDSCC), along with The American Academy of Dermatology recommends conducting annual skin exams to look for the ABCDE’s of skin cancer. A is for Asymmetry: One half of the mole looks different from the other half. B is for Border: The mole has an irregular or poorly defined border. C is for Color: The mole’s color varies from one area to the next, and may include shades of tan, brown or black, or areas of white, red, or blue. D is for Diameter: May be greater than six millimeters, or about the size of a pencil eraser, and can be smaller when diagnosed. E is for Evolving: The mole or lesion is changing in size, shape, or color over time.

Wear sunscreen: Liberally apply sunscreen to all exposed areas of your skin when going outdoors. It’s important to read the label of your sunscreen to make certain it is water-resistant and broad-spectrum with an SPF of 30 or higher. If you are sweating or swimming, you’ll need to reapply every two hours.

Cover up: Sunscreen is only one part of protecting yourself from the sun’s powerful UV rays. In addition to using it, you should wear protective clothing to guarantee extra coverage. Fortunately, lots of companies make long-sleeved and lightweight shirts, pants, hats and sunglasses with UV protection built in. Make use of these especially when around reflective surfaces like the sand, water, and snow. And when you can, during the hours of 10 a.m. and 2 p.m., try to stay under shaded areas since the sun’s UV rays are strongest during that time frame.

Avoid tanning beds: Researchers estimate that indoor tanning may cause upwards of 400,000 cases of skin cancer in the United States each year. Luckily there are alternatives to achieving a sun-kissed glow without UV rays with the use of sunless tanning lotions and spray tanning.

Are you in the know?

  • More than two people die of skin cancer every hour.
  • If you’ve had more than five sunburns, your risk of melanoma has doubled.
  • Melanoma is the second most common form of cancer in females ages 15-29 and is increasing faster in females in this age group than in males of the same age group.
  • It is estimated that melanoma will affect 1 in 27 men and 1 in 40 women in their lifetime.
  • The five-year survival rate for people whose melanoma is detected and treated is 99 percent.

Florida Dermatology and Skin Cancer Centers provides a full spectrum of dermatology and skin care services, and its team of physicians, ARNPs, and PAs are experts in diagnosing and treating skin cancers with the latest technological options. Dr. K. Wade Foster is fellowship-trained in Mohs surgery, the most effective technique for most types of skin cancers, with minimal scarring or risk.

“We bring an unmatched level of services to all of our patients and are confident in our approach to treat skin cancer most effectively and efficiently,” says Dr. Foster. “Fortunately, skin cancer treatment, specifically melanoma, has a very favorable outcome since if it is detected early, it’s almost always treatable.”

For more information about services that Florida Dermatology and Skin Cancer Centers provides, or to make an appointment for a skin exam, visit http://www.fldscc.com or contact us at 863.293.2147.

About Florida Dermatology and Skin Cancer Centers

Florida Dermatology and Skin Cancer Centers, based in Winter Haven, Florida, treats all types of skin and scalp conditions. Medical director K. Wade Foster, MD, PhD, is Fellowship-trained in Mohs surgery, which is the most effective technique for most skin cancers, with minimal scarring or risk. Several convenient locations serve patients throughout Florida. Complete office listings are available online.

For more information about Florida Dermatology and Skin Cancer Centers, visit http://www.fldscc.com or contact Cora Ligon at 863.838.5475. Follow our momentum on Facebook, Instagram, Twitter, and the Florida Dermatology and Skin Cancer Centers blog.

Share article on social media or email:

Top Organizations Share Interactive Resources from AllenComm and Columbia University Department of Psychiatry for Coping with COVID-19


As a service to the community, AllenComm and the Columbia University Department of Psychiatry released two online guides that teach coping skills for getting through the COVID-19 outbreak. COVID-19: Tips for Facing the Lockdown and COVID-19: 5 Tips to Face Your Anxiety have now been distributed by recognizable companies such as Change Healthcare, Chick-Fil-A, and several others.

The organizations that have shared these resources have a strong commitment to the morale of their teams and communities. Their leadership has prompted them to ensure their employees have the resources they need to weather this difficult time.

“I went through [the guide] and was pleased to see it was echoing a lot of what we’ve been sharing with our teams as well,” said one executive. “I will definitely forward it, so others are aware.”

These guides address common frustrations and the anxiety caused by the Coronavirus outbreak. Laid out in easy-to-navigate modules, the guides cover helpful topics such as evaluating helpful vs. harmful thoughts, regulating your mood, changing the stories you tell yourself to ease anxiety, using mindfulness to accept what can’t be changed, finding ways to treat yourself and keep your mind and body active, harnessing the power of changing up your routine to alter your perspective, and finding ways to preserve or strengthen your relationships.

“There are simple, tried and true techniques that psychologists have developed that we can all use to get us through this difficult time,” says Dr. Barbara Stanley, writer of COVID-10: Tips for Facing the Lockdown.

These resources can be accessed by anyone with an internet connection on their mobile device or computer. These guides can also be hosted on corporate, educational, and governmental learning management systems free of charge. Contact AllenComm for more information.

“We are committed to sharing these effective coping skills with our clients and partners,” said Ron Zamir, AllenComm CEO. “While our country focuses on the medical care of so many Americans, we shouldn’t forget that our mental health is under assault. During these times of crisis, we are honored to have developed a resource that is quickly becoming so valuable to businesses and communities.”

About AllenComm

For over 35 years, AllenComm has partnered with Fortune 100 companies to create and scale unique, innovative learning solutions. Extensive instructional design experience, innovative learning technologies, and agency-level creative teams enable AllenComm to stand out in the learning landscape. Considered one of the top ten firms of its kind in the country, AllenComm wins over 40 awards year after year for their tailored learning solutions. With internal workforce and experience, AllenComm is uniquely positioned in the learning space to meet multiple needs from small to very large change management projects. Partnering with AllenComm to supplement and support human capital management needs has helped customers reduce expenses, shorten onboarding periods, and raise the impact of sales and compliance efforts.

For more information, visit allencomm.com.

About Columbia University Department of Psychiatry

The Columbia University Department of Psychiatry is one of the largest in the country in terms of faculty size as well as state, federal, and foundation research support. They are currently among the top-ranked in the nation for Psychiatry in the US News & World Report Best Hospital rankings, as well as in psychiatric research funding from the National Institutes of Health. They have extraordinary clinical, educational, and research resources. Their faculty includes over 400 psychiatrists, psychologists, social workers, nurses, and neurobehavioral scientists. Clinical facilities and laboratories of the Psychiatry Department are located in a large number of institutions and healthcare systems. These include New York-Presbyterian Hospital, Columbia University Irving Medical Center, the New York State Psychiatric Institute, the New York State Office of Mental Health, and the Washington Heights Community Mental Health Center. The Department of Psychiatry also houses the Center for Neurobiology and Behavior, the Mind/Brain Institute, a Howard Hughes Research Institute, and the Stanley Center for Applied Neuroscience of Bipolar Disorders.

Share article on social media or email:

TreCeuticals Physician-Developed Solutions Restore and Regenerate Skin through Simplified Product Regimen


Best friends and founders of BellaTres

We noticed a lot of confusion with most skincare products. The use of active ingredients is key. These ingredients have to be formulated at a high enough level to produce results.

BellaTres is excited to announce TreCeuticals, a line of scientifically-formulated solutions for those wanting improved texture, tone, and elasticity of facial skin. The company was founded by three friends passionate about skincare who decided to create a very specific, easy-to-use system that is also gender neutral.

“We noticed a lot of confusion with most skincare products. The use of active ingredients is key. These ingredients have to be formulated at a high enough level to produce results,” say the founders. The products will be available through a convenient ship-to-home program, starting April 30th, 2020.

The unique skincare system, developed with the guidance of renowned Facial Aesthetic Surgeon Dr. Paul Holden, fills a need in the self-care routine of busy consumers who want safe and effective skin benefits in a streamlined system.

Holden commented, “After listening to my patients for more than a decade, it became clear they desired an easy, effective, and accessible regimen for their skin that gives great results immediately and long term. Our development team at TreCeuticals has now delivered a science-based product that is unique, simple-to-use and shows significant, sustained improvement. People are going to be amazed at the difference in the way they look and feel after the first week of use.”

TreCeuticals offers these nourishing products without the hassle of buying from a dermatology clinic. Since the products are shipped soon after production, consumers receive the product at maximum potency – something that can’t always be guaranteed with off-the-shelf alternatives. There’s an added benefit of efficiency, as well.

The founding partners explained, “Our packaging is carefully measured and labeled so that you get the best, most effective use from each part of our kit.”

Users can feel better about their purchase, knowing that there won’t be excess product or bulky packaging to discard. The entire line is also cruelty-free.

TreCeuticals offers the luxury customers expect in a quality product without the high price or stress of traditional “systems.” Learn more at TreCeuticals SkinCare

Share article on social media or email: